About the SA Blog Network



Opinion, arguments & analyses from the editors of Scientific American
Observations HomeAboutContact

What’s in your gut? Microbiota categories might help simplify personalized medicine

The views expressed are those of the author and are not necessarily those of Scientific American.

Email   PrintPrint

bacteria in your gutThe diverse wilderness of life inside of our bodies is just starting to gain the attention of scientists. The human gut alone typically holds some 100,000 billion bitty bacteria, and with no two people’s microbiomes being the same, classifying these crucial organisms has been challenging.

A new study, published online April 20 in Nature, proposes a simple schematic for profiling people’s gut microbiota, breaking down these helpful hangers-on into three overarching categories. (Scientific American is part of Nature Publishing Group.)

"The three gut types can explain why the uptake of medicines and nutrients varies from person to person," Jeroen Raes, a bioinformatician at Vrije University in Brussels and coauthor of the new study, said in a prepared statement. "This knowledge could form the basis of personalized therapies," by basing treatments on the known metabolic tendencies of a person’s microbiota category.

The study profiled the gut flora of 39 people from Europe, the U.S. and Japan and found that categories were not dependent on location—or on age, gender or body mass index.

"We may have uncovered a new ‘biological fingerprint’ on the same level as blood types and tissue types," Oluf Borbye Pedersen, a professor at the Faculty of Health Sciences at the University of Copenhagen and a research on the study, said in a prepared statement. Having one of the three types, which are characterized by a dominate genus of bacterium—Bacteroides, Prevotella or Ruminococcus—might play a large role in determining how you metabolize food to what vitamins your stomach is good at formulating (those in the Bacteroides group, for example, had a gut environment that was better at making vitamins B2, B5, C and H; those in the Prevotella group had more B1 and folic acid-making bacteria).

The researchers point out that this profiling is still in an early stage, but, Pedersen noted, down the line the new discoveries "may be translated into individual diet advice or design of drugs that are adapted to the individual."

Image courtesy of iStockphoto/kaarsten

Rights & Permissions

Comments 2 Comments

Add Comment
  1. 1. kchri259 10:03 am 04/21/2011

    Is there a way to receive RSS feeds or to be informed about this research as it unfolds. I find ths very useful and factinating information, though I am not surprised.

    Link to this
  2. 2. SpoonmanWoS 2:01 pm 04/21/2011

    I searched for the author of the paper, and there doesn’t appear to be a feed per se, but he is on Twitter: jeroenraes. Keep in mind, this is a preliminary study to determine if there’s a need to study this topic further. It may not be Raes who continues the research, and even if he does it might be years before any significant breakthrough is announced. This type of research will more likely be "integrated" into other research, such as the effects of specific medicines, etc.

    Science isn’t linear. A discovery does not necessarily lead to further research into that discovery, but the impact it has on other areas. This IS a pretty significant discovery,though,and I have a feeling we’re going to be looking at this in the future as one of the turning points for medical research.

    Link to this

Add a Comment
You must sign in or register as a member to submit a comment.

More from Scientific American

Email this Article